Lyra Therapeutics
LYRA
#9768
Rank
NZ$18.79 M
Marketcap
$0.29
Share price
-6.39%
Change (1 day)
-94.01%
Change (1 year)

P/S ratio for Lyra Therapeutics (LYRA)

P/S ratio as of November 2024 (TTM): 6.02

According to Lyra Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.3539. At the end of 2024 the company had a P/S ratio of 9.27.

P/S ratio history for Lyra Therapeutics from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.27-94.76%
2023177141.11%
202273.3-63.15%
2021199
2020N/A